Tin tức & Cập nhật

Dapagliflozin improves symptoms, physical limitations in HFpEF
Dapagliflozin improves symptoms, physical limitations in HFpEF
13 Oct 2021 bởiRoshini Claire Anthony

Patients with heart failure and preserved ejection fraction (HFpEF) treated with dapagliflozin experienced improvements in symptoms and physical limitations, according to results of the PRESERVED-HF study presented at HFSA 2021.

Dapagliflozin improves symptoms, physical limitations in HFpEF
13 Oct 2021
Mediterranean diet may brighten outlook in polyvascular atherosclerotic disease
Mediterranean diet may brighten outlook in polyvascular atherosclerotic disease
13 Oct 2021

Adherence to a Mediterranean dietary pattern among polyvascular atherosclerotic disease (PAD) patients leads to improvements in inflammatory and metabolic status, which may potentially translate into better long-term cardiovascular outcomes, according to a study.

Mediterranean diet may brighten outlook in polyvascular atherosclerotic disease
13 Oct 2021
Ticagrelor after abbreviated DAPT minimizes bleeding while preserving efficacy in ACS
Ticagrelor after abbreviated DAPT minimizes bleeding while preserving efficacy in ACS
12 Oct 2021
Mild cognitive impairment common in hypertensive patients
Mild cognitive impairment common in hypertensive patients
12 Oct 2021

Mild cognitive impairment (MCI) is common among patients with hypertension, reports a recent meta-analysis. Early screening is needed in this population to facilitate timely intervention.

Mild cognitive impairment common in hypertensive patients
12 Oct 2021
Continuous vital sign monitoring catches COVID-19 deterioration early
Continuous vital sign monitoring catches COVID-19 deterioration early
11 Oct 2021